Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus

Lupus. 2016 Jan;25(1):81-7. doi: 10.1177/0961203315606982. Epub 2015 Sep 24.

Abstract

Objective: Caspase-1 is required for nephritis and robust autoantibody development in the pristane model of murine lupus. The objective of this study was to evaluate the immune response and to study the splenic B and T cell populations in wild-type (WT) and caspase-1-/- mice following pristane injection in order to develop an understanding of why absence of caspase-1 is protective in pristane-induced lupus.

Methods: Immunization responses to NP-Ficoll and NP-ovalbumin were assessed in WT and caspase-1-/- mice. In vitro IgM and IgG responses to R848 were measured by ELISA. Serum IgM anti-dsDNA and IL-1β were also measured by ELISA. B and T cell populations 2 weeks and 6 months following pristane injection were measured by flow cytometry in WT and caspase-1-/- mice.

Results: Caspase-1-/- mice generate equivalent IgG responses to NP-Ficoll and NP-ova antigens when compared to wild-type mice. Additionally, they secrete IgM and IgG in response to TLR7 activation. Pristane injected WT and caspase-1-/- mice generate robust IgM anti-dsDNA responses. Caspase-1-/- mice have a significant reduction in marginal zone B cell populations compared to WT 6 months after pristane exposure whereas T cell responses are intact in these mice.

Conclusions: Caspase-1-/- mice have intact immune responses but do not develop an expanded marginal zone B cell population in response to pristane-induced lupus. This may be one explanation for reduced IgG autoantibody production in these mice.

Keywords: B-cell; Caspase-1; autoantibody; lupus.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Antinuclear / blood
  • B-Lymphocytes / enzymology*
  • B-Lymphocytes / immunology
  • Caspase 1 / deficiency*
  • Caspase 1 / genetics
  • Cells, Cultured
  • Disease Models, Animal
  • Ficoll / administration & dosage
  • Ficoll / analogs & derivatives
  • Ficoll / immunology
  • Genetic Predisposition to Disease
  • Imidazoles / administration & dosage
  • Imidazoles / immunology
  • Immunization
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Lupus Erythematosus, Systemic / chemically induced
  • Lupus Erythematosus, Systemic / enzymology*
  • Lupus Erythematosus, Systemic / genetics
  • Lupus Erythematosus, Systemic / immunology
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Nitrophenols / administration & dosage
  • Nitrophenols / immunology
  • Ovalbumin / administration & dosage
  • Ovalbumin / immunology
  • Phenotype
  • Phenylacetates / administration & dosage
  • Phenylacetates / immunology
  • Spleen / enzymology*
  • Spleen / immunology
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / immunology
  • Terpenes*
  • Time Factors

Substances

  • Antibodies, Antinuclear
  • Imidazoles
  • Immunoglobulin G
  • Immunoglobulin M
  • Nitrophenols
  • Phenylacetates
  • Terpenes
  • 4-hydroxy-5-nitrophenyl acetic acid
  • Ficoll
  • pristane
  • Ovalbumin
  • Caspase 1
  • resiquimod